Intestinal Research

IBD
Which biologic agents increase perioperative complications in patients with inflammatory bowel disease?: Jihye Park; Intest Res. 2022;20(1):1-2. Published online January 26, 2022; DOI: https://doi.org/10.5217/ir.2021.00170
Cited By 1; Full text PubReader ePub PDF

Management of inflammatory bowel disease in the COVID-19 era: Kyeong Ok Kim, Byung Ik Jang; Intest Res. 2022;20(1):3-10. Published online February 3, 2021; DOI: https://doi.org/10.5217/ir.2020.00156
Cited By 16; Full text PubReader ePub PDF

Use of thiopurines in inflammatory bowel disease: an update: Arshdeep Singh, Ramit Mahajan, Saurabh Kedia, Amit Kumar Dutta, Abhinav Anand, Charles N. Bernstein, Devendra Desai, C. Ganesh Pai, Govind Makharia, Harsh Vardhan Tevethia, Joyce WY Mak, Kirandeep Kaur, Kiran Peddi, Mukesh Kumar Ranjan, Perttu Arkkila, Rakesh Kochhar, Rupa Banerjee, Saroj Kant Sinha, Siew Chien Ng, Stephen Hanauer, Suhang Verma, Usha Dutta, Vandana Midha, Varun Mehta, Vineet Ahuja, Ajit Sood; Intest Res. 2022;20(1):11-30. Published online April 15, 2021; DOI: https://doi.org/10.5217/ir.2020.00155
Cited By 29; Full text PubReader ePub PDF

Microbiota
The role of microbiome in colorectal carcinogenesis and its clinical potential as a target for cancer treatment: Sang Hoon Kim, Yun Jeong Lim; Intest Res. 2022;20(1):31-42. Published online May 21, 2021; DOI: https://doi.org/10.5217/ir.2021.00034
Cited By 17; Full text PubReader ePub PDF

IBD
An integrative review of physical activity in adults with inflammatory bowel disease: Suja P Davis, Patricia B. Crane, Linda P. Bolin, Lee Ann Johnson; Intest Res. 2022;20(1):43-52. Published online January 22, 2021; DOI: https://doi.org/10.5217/ir.2020.00049
Cited By 8; Full text PubReader ePub PDF Supplementary Material

The dietary practices and beliefs of British South Asian people living with inflammatory bowel disease: a multicenter study from the United Kingdom: Benjamin Crooks, Ravi Misra, Naila Arebi, Klaartje Kok, Matthew J. Brookes, John McLaughlin, Jimmy K. Limdi; Intest Res. 2022;20(1):53-63. Published online January 6, 2021; DOI: https://doi.org/10.5217/ir.2020.00079
Cited By 8; Full text PubReader ePub PDF Supplementary Material

Maintaining infliximab induced clinical remission with azathioprine and 5-aminosalicylates in acute severe steroid-refractory ulcerative colitis has lower cost and high efficacy (MIRACLE): a multicenter study: Ramit Mahajan, Arshdeep Singh, Saurabh Kedia, Kirandeep Kaur, Vandana Midha, Pabitra Sahu, Varun Mehta, Dharmatma Singh, Namita Bansal, Khushdeep Dharni, Sandeep Kaushal, Vineet Ahuja, Ajit Sood; Intest Res. 2022;20(1):64-71. Published online February 3, 2021; DOI: https://doi.org/10.5217/ir.2020.00100
Cited By 9; Full text PubReader ePub PDF

Vedolizumab does not increase perioperative surgical complications in patients with inflammatory bowel disease, cohort study: Vitaliy Y. Poylin, Jose Cataneo Serrato, Jonathan Pastrana Del Valle, Joseph D. Feuerstein; Intest Res. 2022;20(1):72-77. Published online February 3, 2021; DOI: https://doi.org/10.5217/ir.2020.00117
Cited By 8; Full text PubReader ePub PDF

Effectiveness of administering zinc acetate hydrate to patients with inflammatory bowel disease and zinc deficiency: a retrospective observational two-center study: Kensuke Sakurai, Shigeru Furukawa, Takehiko Katsurada, Shinsuke Otagiri, Kana Yamanashi, Kazunori Nagashima, Reizo Onishi, Keiji Yagisawa, Haruto Nishimura, Takahiro Ito, Atsuo Maemoto, Naoya Sakamoto; Intest Res. 2022;20(1):78-89. Published online January 22, 2021; DOI: https://doi.org/10.5217/ir.2020.00124
Cited By 5; Full text PubReader ePub PDF Supplementary Material

Long-term efficacy and tolerability of dose-adjusted thiopurine treatment in maintaining remission in inflammatory bowel disease patients with NUDT15 heterozygosity: Takato Maeda, Hirotake Sakuraba, Hiroto Hiraga, Shukuko Yoshida, Yoichi Kakuta, Hidezumi Kikuchi, Shogo Kawaguchi, Keisuke Hasui, Tetsuya Tatsuta, Daisuke Chinda, Tatsuya Mikami, Shinsaku Fukuda; Intest Res. 2022;20(1):90-100. Published online January 22, 2021; DOI: https://doi.org/10.5217/ir.2020.00133
Cited By 3; Full text PubReader ePub PDF Supplementary Material Graphic abstract

Biomarker dynamics during infliximab salvage for acute severe ulcerative colitis: C-reactive protein (CRP)-lymphocyte ratio and CRP-albumin ratio are useful in predicting colectomy: Danny Con, Bridgette Andrew, Steven Nicolaides, Daniel R van Langenberg, Abhinav Vasudevan; Intest Res. 2022;20(1):101-113. Published online March 12, 2021; DOI: https://doi.org/10.5217/ir.2020.00146
Cited By 13; Full text PubReader ePub PDF Supplementary Material

Incidence comparison of adverse events in patients with inflammatory bowel disease receiving different biologic agents: retrospective long-term evaluation: Brigida Barberio, Edoardo Vincenzo Savarino, Timothy Card, Cristina Canova, Francesco Baldisser, Alessandro Gubbiotti, Davide Massimi, Matteo Ghisa, Fabiana Zingone; Intest Res. 2022;20(1):114-123. Published online August 4, 2021; DOI: https://doi.org/10.5217/ir.2021.00037
Cited By 9; Full text PubReader ePub PDF Supplementary Material

Functional bowel disorder
An evaluation of dietary adequacy among patients with constipation-predominant irritable bowel syndrome in Malaysia: Nor Hamizah Shafiee, Nurul Huda Razalli, Norfilza M. Mokhtar, Eunice Tan, Raja Affendi Raja Ali; Intest Res. 2022;20(1):124-133. Published online January 22, 2021; DOI: https://doi.org/10.5217/ir.2020.00050
Cited By 6; Full text PubReader ePub PDF

IBD
Clinical presentation of COVID-19 in patients with inflammatory bowel disease: a systematic review and meta-analysis: Anupam K. Singh, Anuraag Jena, Praveen Kumar-M, Daya Krishna Jha, Vishal Sharma; Intest Res. 2022;20(1):134-143. Published online January 18, 2021; DOI: https://doi.org/10.5217/ir.2020.00108
Cited By 11; Full text PubReader ePub PDF Supplementary Material

Miscellaneous
A case of autoimmune enteropathy with CTLA4 haploinsufficiency: Haruka Miyazaki, Namiko Hoshi, Michitaka Kohashi, Eri Tokunaga, Yuna Ku, Haruka Takenaka, Makoto Ooi, Nobuyuki Yamamoto, Suguru Uemura, Noriyuki Nishimura, Kazumoto Iijima, Keisuke Jimbo, Tsubasa Okano, Akihiro Hoshino, Kohsuke Imai, Hirokazu Kanegane, Ichiro Kobayashi, Yuzo Kodama; Intest Res. 2022;20(1):144-149. Published online January 22, 2021; DOI: https://doi.org/10.5217/ir.2020.00041
Cited By 5; Full text PubReader ePub PDF

IBD
Granulocyte and monocyte apheresis therapy for patients with active ulcerative colitis associated with COVID-19: a case report: Miki Koroku, Teppei Omori, Harutaka Kambayashi, Shun Murasugi, Tomoko Kuriyama, Yuichi Ikarashi, Maria Yonezawa, Ken Arimura, Kazunori Karasawa, Norio Hanafusa, Masatoshi Kawana, Katsutoshi Tokushige; Intest Res. 2022;20(1):150-155. Published online March 12, 2021; DOI: https://doi.org/10.5217/ir.2020.00148
Cited By 2; Full text PubReader ePub PDF

Previous issues